Alzinova AB (OSTO:ALZ) ROE % Adjusted to Book Value : -8.29% (As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Alzinova AB ROE % Adjusted to Book Value?

Alzinova AB's ROE % for the quarter that ended in Dec. 2024 was -20.65%. Alzinova AB's PB Ratio for the quarter that ended in Dec. 2024 was 2.49. Alzinova AB's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was -8.29%.

Alzinova AB ROE % Adjusted to Book Value Historical Data

The historical data trend for Alzinova AB's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alzinova AB ROE % Adjusted to Book Value Chart

Alzinova AB Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-6.65

-7.12

-15.87

-12.62

-6.94

Alzinova AB Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-13.68	-23.76	-28.63	-5.76	-8.29

Competitive Comparison of Alzinova AB's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Alzinova AB's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alzinova AB's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alzinova AB's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Alzinova AB's ROE % Adjusted to Book Value falls into.

Alzinova AB ROE % Adjusted to Book Value Calculation

Alzinova AB's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-17.29%	/	2.49
	=	-6.94%

Alzinova AB's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-20.65%	/	2.49
	=	-8.29%

Alzinova AB ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Alzinova AB's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Alzinova AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alzinova AB (OSTO:ALZ) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

78D:Germany

Address

Pepparedsleden 1, Molndal, SWE, SE-431 83

Website

https://www.alzinova.com

Alzinova AB is a Swedish biotechnology company engaged in the discovery and development of therapeutics for the treatment of Alzheimer's disease. The company is engaged in the development of a specific oligomer-directed vaccine (ALZ-101), and ALZ-201 which is a monoclonal antibody that is specific for the toxic AB oligomers. The products of the company are in the clinical and preclinical stages of development as a therapeutic vaccine for the treatment of Alzheimer's.

Alzinova AB Headlines

No Headlines